Skip to main content
. 2015 Jan 23;2015(1):CD004903. doi: 10.1002/14651858.CD004903.pub4

Munoz 2001.

Methods The study was a prospective, double‐blind, randomized, controlled trial.
Participants Country: United States.
 Number: 20 women in the intervention group and 40 women in the control group.
Mean age: 30.2 years.
Mean gestational age: 33.3 weeks.
Interventions 23‐valent pneumococcal polysaccharide vaccine vs Hemophilus influenzae type b conjugate vaccine.
Outcomes Incidence of neonatal and infant pneumococcal colonization.
 Neonatal antibody levels (GM).
 Maternal antibody levels (GM).
 Incidence of tenderness at the injection site.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Details were not reported.
Allocation concealment (selection bias) Unclear risk Details were not reported.
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Quote: “double blind”.
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Quote: “double blind”.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk 2/60 were lost to follow‐up.
Selective reporting (reporting bias) Low risk All outcomes were predefined and reported.
Other bias Low risk The trial appears to be free of industry sponsorship.